If you have advanced nonsquamous NSCLC, ask your doctor if a plan that starts with ALIMTA and stays with ALIMTA may be right for you.
ALIMTA can suppress bone marrow function, which may cause low blood cell counts.
Understanding more about your type of lung cancer and your treatment options may seem
overwhelming. This site is designed to help you learn more about your condition and play a more
active role in your care. The site includes information about ALIMTA® (pemetrexed for injection) therapy for advanced
nonsquamous NSCLC and malignant pleural mesothelioma (MPM).